Combatting resistant enterococcal infections: a pharmacotherapy review-Reference-Cited by-同舟云学术

Combatting resistant enterococcal infections: a pharmacotherapy review

Published:2018-06-07 Issue:9 Volume:19 Page:979-992
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Mercuro Nicholas J¹²,Davis Susan L¹²,Zervos Marcus J³⁴,Herc Erica S³

Affiliation:

1. Pharmacy Services, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI, USA

2. Pharmacy Services, Henry Ford Hospital, Detroit, MI, USA

3. Department of Internal Medicine, Division of Infectious Diseases, Henry Ford Hospital, Detroit, MI, USA

4. Wayne State University School of Medicine, Detroit, MI, USA

Funder

not funded

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2018.1479397

Reference115 articles.

1. Enterococci

2. Centers for Disease Control and Prevention. drug resistance, biggest threats. 2016[cited 2017 Oct 18]. Available from: https://www.cdc.gov/drugresistance/biggest_threats.html

3. A CASE OF ACUTE ENDOCARDITIS CAUSED BY MICROCOCCUS ZYMOGENES (NOV. SPEC.), WITH A DESCRIPTION OF THE MICROORGANISM

4. Antimicrobial drug development – the past, the present, and the future

5. Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Q48K mutation in the type IB nitroreductase NrmA is responsible for nitrofurantoin resistance in Enterococcus faecium;International Journal of Antimicrobial Agents;2024-09

2. Analysis of molecular epidemiological characteristics and antimicrobial susceptibility of vancomycin-resistant and linezolid-resistant Enterococcus in China;BMC Medical Genomics;2024-07-01

3. Four-year variation in pathogen distribution and antimicrobial susceptibility of urosepsis: a single-center retrospective analysis;Therapeutic Advances in Infectious Disease;2024-01

4. The Synergistic Activity of Rhamnolipid Combined with Linezolid against Linezolid-Resistant Enterococcus faecium;Molecules;2023-11-16

5. Vancomycin-resistant enterococcus bloodstream infection successfully managed with oritavancin and fosfomycin as sequential treatment;Journal of Chemotherapy;2023-08-21